The $75,000 grant from the Resmed Foundation will fund a clinical research project examining how obstructive sleep apnea impacts recovery in inpatient rehabilitation settings.

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. CMS proposed rule: Physician fee schedule CMS has re...

New data from a long-term extension study demonstrates sustained improvements in wakefulness, cognition, and fatigue for adults with narcolepsy type 1 and type 2.

Incannex Healthcare has initiated screening for its DReAMzz dose confirmation study evaluating IHL-42X for obstructive sleep apnea.

On July 14, the Centers for Medicare & Medicaid Services (CMS) released the 2027 physician fee schedule (PFS) proposed rule. The proposal includes payment updates, telehealth policies, and several initiatives that co...

On July 12, Pennsylvania Governor Josh Shapiro signed into law HB 1505, a state budget package, which included a provision permitting school districts to redirect existing funding streams, to cover the costs of planning,...

The oral orexin 2 receptor agonist currently in phase 1b development for patients with narcolepsy.

The Centers for Medicare & Medicaid Services continues to emphasize changes to the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) accreditation process to strengthen oversight of DMEPOS supp...

Recent developments across technology, industry, policy, and research highlight new directions for sleep medicine in the second quarter of 2026. Drawing on AASM’s State of Sleep Q2 2026 updates, this overview summarizes...

As the field of sleep medicine continues to evolve, so do the skills required to lead a successful practice. Reflecting that growth, the AASM Practice Management Course has been reintroduced as the Business of Sleep Medi...